Kellie Combs, Ropes & Gray life sciences partner, analyzes three documents released by the FDA outlining the agency’s current thinking regarding drug and device manufacturers’ communication of information not contained in FDA-approved labeling.
Trending Similar Videos
Value-based health care: private equity investors
Deborah Gersh, Ropes & Gray health care partner, discusses considerations for private equity companies investing in the value-based health care space.
M&A auction process
Phil Sanderson, Ropes & Gray private equity transactions partner, discusses the M&A auction process in the UK.
Cloud computing security
Jim DeGraw, Ropes & Gray technology partner, addresses cloud computing security issues that companies should be aware of as they consider moving data to the cloud.
Value-based health care: fraud & abuse laws
Michael Lampert, Ropes & Gray health care partner, discusses fraud and abuse law application to value-based health care arrangements.
Value-based health care: data & technology
Ira Parghi, Ropes & Gray health care counsel, discusses the increasing role that data and technology will play in a value-based health care world.
Compliance strategies for global life sciences companies
Kim Nemirow, Ropes & Gray government enforcement partner, analyzes new compliance strategies global life sciences companies are facing in an evolving market.